Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT
Sanjay Asthana, MD close
L_W9Tvc6Yfw
Sanjay Asthana, MD
 


For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Sanjay Asthana, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Sanjay Asthana earned his medical degree from the University of Delhi in India and completed his residency at the University of Saskatchewan School of Medicine in Saskatchewan, Canada. His research interests include the therapeutic potential of estrogen and raloxifene for postmenopausal women with Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI).

Specialties

Geriatrics (Specialty Care)

UW Health Clinics

University Station Clinic
(608) 263-7740 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Internal Medicine
Geriatric Medicine
Fellowship Johns Hopkins Hospital, Baltimore, MD
Residency University of Saskatchewan School of Medicine, Saskatchewan, Canada
Internship Safdurjung Hospital, New Delhi, India
Medical School University of Delhi, India, 1980

Awards/Honors

Best Doctors® in America 2014

Best Doctors® in America 2013

Madison Magazine Top Docs 2012

Best Doctors® in America 2011


Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Programs & Conditions

PubMed Articles
Mielke MM Haughey NJ Bandaru VV Zetterberg H Blennow K Andreasson U Johnson SC Gleason CE Blazel HM Puglielli L Sager MA Asthana S Carlsson CM . Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease. Neurobiol Aging. 2014 Nov;35(11):2486-94
[PubMed ID: 24952994]
Boots EA Schultz SA Oh JM Larson J Edwards D Cook D Koscik RL Dowling MN Gallagher CL Carlsson CM Rowley HA Bendlin BB LaRue A Asthana S Hermann BP Sager MA Johnson SC Okonkwo OC . Cardiorespiratory fitness is associated with brain structure, cognition, and mood in a middle-aged cohort at risk for Alzheimer's disease. Brain Imaging Behav. 2014 Oct 16;
[PubMed ID: 25319359]
Okonkwo OC Schultz SA Oh JM Larson J Edwards D Cook D Koscik R Gallagher CL Dowling NM Carlsson CM Bendlin BB LaRue A Rowley HA Christian BT Asthana S Hermann BP Johnson SC Sager MA . Physical activity attenuates age-related biomarker alterations in preclinical AD. Neurology. 2014 Oct 8;
[PubMed ID: 25298312]
Willette AA Johnson SC Birdsill AC Sager MA Christian B Baker LD Craft S Oh J Statz E Hermann BP Jonaitis EM Koscik RL La Rue A Asthana S Bendlin BB . Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement. 2014 Jul 17;
[PubMed ID: 25043908]
Okonkwo OC Xu G Oh JM Dowling NM Carlsson CM Gallagher CL Birdsill AC Palotti M Wharton W Hermann BP LaRue A Bendlin BB Rowley HA Asthana S Sager MA Johnson SC . Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. Cereb Cortex. 2014 Apr;24(4):978-88
[PubMed ID: 23236200]
Fischer B Gleason C Asthana S . Effects of hormone therapy on cognition and mood. Fertil Steril. 2014 Apr;101(4):898-904
[PubMed ID: 24680649]
Okonkwo OC Oh JM Koscik R Jonaitis E Cleary CA Dowling NM Bendlin BB Larue A Hermann BP Barnhart TE Murali D Rowley HA Carlsson CM Gallagher CL Asthana S Sager MA Christian BT Johnson SC . Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease. J Int Neuropsychol Soc. 2014 Apr;20(4):422-33
[PubMed ID: 24621494]
Johnson SC Christian BT Okonkwo OC Oh JM Harding S Xu G Hillmer AT Wooten DW Murali D Barnhart TE Hall LT Racine AM Klunk WE Mathis CA Bendlin BB Gallagher CL Carlsson CM Rowley HA Hermann BP Dowling NM Asthana S Sager MA . Amyloid burden and neural function in people at risk for Alzheimer's Disease. Neurobiol Aging. 2014 Mar;35(3):576-84
[PubMed ID: 24269021]
Dysken MW Guarino PD Vertrees JE Asthana S Sano M Llorente M Pallaki M Love S Schellenberg GD McCarten JR Malphurs J Prieto S Chen P Loreck DJ Carney S Trapp G Bakshi RS Mintzer JE Heidebrink JL Vidal-Cardona A Arroyo LM Cruz AR Kowall NW Chopra MP Craft S Thielke S Turvey CL Woodman C Monnell KA Gordon K Tomaska J Vatassery G . Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data. Alzheimers Dement. 2014 Jan;10(1):36-44
[PubMed ID: 23583234]
Wharton W Gleason CE Dowling NM Carlsson CM Brinton EA Santoro MN Neal-Perry G Taylor H Naftolin F Lobo RA Merriam G Manson JE Cedars MI Miller VM Black DM Budoff M Hodis HN Harman SM Asthana S . The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition. J Alzheimers Dis. 2014;40(2):331-41
[PubMed ID: 24430001]
Dysken MW Sano M Asthana S Vertrees JE Pallaki M Llorente M Love S Schellenberg GD McCarten JR Malphurs J Prieto S Chen P Loreck DJ Trapp G Bakshi RS Mintzer JE Heidebrink JL Vidal-Cardona A Arroyo LM Cruz AR Zachariah S Kowall NW Chopra MP Craft S Thielke S Turvey CL Woodman C Monnell KA Gordon K Tomaska J Segal Y Peduzzi PN Guarino PD . Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014 Jan 1;311(1):33-44
[PubMed ID: 24381967]
Racine AM Adluru N Alexander AL Christian BT Okonkwo OC Oh J Cleary CA Birdsill A Hillmer AT Murali D Barnhart TE Gallagher CL Carlsson CM Rowley HA Dowling NM Asthana S Sager MA Bendlin BB Johnson SC . Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation. Neuroimage Clin. 2014;4:604-14
[PubMed ID: 24936411]
Dowling NM Gleason CE Manson JE Hodis HN Miller VM Brinton EA Neal-Perry G Santoro MN Cedars M Lobo R Merriam GR Wharton W Naftolin F Taylor H Harman SM Asthana S . Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance. PLoS One. 2013;8(7):e68741
[PubMed ID: 23874743]
Birdsill AC Carlsson CM Willette AA Okonkwo OC Johnson SC Xu G Oh JM Gallagher CL Koscik RL Jonaitis EM Hermann BP LaRue A Rowley HA Asthana S Sager MA Bendlin BB . Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity (Silver Spring). 2013 Jul;21(7):1313-20
[PubMed ID: 23687103]
Wharton W Gleason CE Miller VM Asthana S . Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog). Brain Res. 2013 Jun 13;1514:12-7
[PubMed ID: 23603409]
Willette AA Xu G Johnson SC Birdsill AC Jonaitis EM Sager MA Hermann BP La Rue A Asthana S Bendlin BB . Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care. 2013 Feb;36(2):443-9
[PubMed ID: 23069842]
Kind AJ Jensen L Barczi S Bridges A Kordahl R Smith MA Asthana S . Low-cost transitional care with nurse managers making mostly phone contact with patients cut rehospitalization at a VA hospital. Health Aff (Millwood). 2012 Dec;31(12):2659-68
[PubMed ID: 23213150]
Carlsson CM Xu G Wen Z Barnet JH Blazel HM Chappell RJ Stein JH Asthana S Sager MA Alsop DC Rowley HA Fain SB Johnson SC . Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's disease: a pilot study. Curr Alzheimer Res. 2012 Oct;9(8):990-7
[PubMed ID: 22175654]
Wharton W Gleason CE Olson SR Carlsson CM Asthana S . Neurobiological Underpinnings of the Estrogen - Mood Relationship. Curr Psychiatry Rev. 2012 Aug 1;8(3):247-256
[PubMed ID: 23990808]
Gleason CE Dowling NM Friedman E Wharton W Asthana S . Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy? Menopause. 2012 May;19(5):524-33
[PubMed ID: 22207317]